MergerJul 16, 2026, 11:03 AM
Aptorum Group Merger with DiamiR to Close; 1-for-10 Reverse Split
AI Summary
Aptorum Group announced that its merger with DiamiR Biosciences Corp. is anticipated to close around July 20, 2026. In connection with the merger, Aptorum will effect a 1-for-10 reverse share split and redomicile as a Delaware company under the new name Niki BioSolutions, Inc. The post-merger company will trade on Nasdaq under the new ticker "NIKI" on a split-adjusted basis, with the reverse split intended to maintain Nasdaq listing compliance.
Key Highlights
- Merger with DiamiR Biosciences Corp. expected to close around July 20, 2026.
- Company to effect a 1-for-10 reverse share split.
- Aptorum to redomicile as a Delaware company, named Niki BioSolutions, Inc.
- Post-merger company to trade on Nasdaq under new ticker "NIKI" (CUSIP 653942 102).
- Reverse split aims to maintain Nasdaq minimum bid price compliance.
- Outstanding Class A shares to reduce from ~6.35M to ~634,682.
- Outstanding Class B shares to reduce from ~1.80M to ~179,693.
Price Impact
More from APM